News Release 

Paternal age over 51 years reduces success rate in IVF and ICSI

Men urged to heed their biological clock and not delay their plans for fatherhood

European Society of Human Reproduction and Embryology

Vienna, 26 June 2019: While female fertility comes to an irrevocable end with the menopause (at a consistently average age of 51 years), men are not constrained by similar biological senescence. Studies have shown that sperm counts may decline and DNA damage in sperm cells may increase over time, but the celebrity fatherhood of ageing actors and rock stars perpetuates the myth that male fertility might last forever.

However, the published evidence does show that men are indeed regulated by a biological clock. Studies have demonstrated a decline in natural male fertility and an increase in miscarriage rate as men get older. So far it is not yet known whether paternal age affects outcomes in IVF and ICSI - or if there is (or should be) any age limit to treatment.

Now, an analysis of almost 5000 IVF/ICSI cycles performed at a single centre in London indicates that success rates do decline significantly after a paternal age of 51 years. Miscarriage rate in this study was not affected by the age of the male partner. Nevertheless, the investigators confirm that paternal age over 51 does significantly affect the chance of success in assisted reproduction, adding that this warrants a call for 'a public health message for men to not delay fatherhood'.

The results of the study are presented today by Dr Guy Morris from the Centre for Reproductive and Genetic Health (CRGH) in London, where this observational retrospective study was performed. The research team from CRGH and the Institute for Women's Health at University College London analysed the records of 4271 men involved in 4833 cycles of IVF and ICSI treatment for all causes of sub-fertility between 2009 and 2018. The male partners were grouped into age ranges of 35 and under, 36-40, 41-44, 45-50, and over 51 years for analysis. A male age and female age under 35 years were used as reference control groups for comparison.

The analysis first showed that fewer men over 51 met the standard WHO semen reference values than did men under 51 (42.1% vs 61.1%,). It was similarly found - as expected - that clinical pregnancy rate declined with increasing maternal age over 35 years - from 51.1% for under-35s to 21.7% for over-40s. Both these trends were statistically significant.(1)

The study also showed that clinical pregnancy rates declined with increasing paternal age - from 49.9% in the under 35 group, to 42.5% in the 36-40s, to 35.2% in the 41-45s, to 32.8% in the 46-50s, and to 30.5% in the over 51s. These results were re-analysed in a statistical model which included maternal age and it was found that, for all maternal age subgroups, the probability of pregnancy still decreased significantly with paternal age over 51 years.

Dr Morris and his colleagues noted that 80% of the cohort's couples with male partners over 51 were treated with ICSI, a treatment developed for male infertility and requiring just one viable sperm cell for fertilisation. However, although 42% of these older male partners did have normal semen parameters (sperm count, sperm motility), he points out that 'this may have confounded the results and reduced the perceived effect of increased paternal age'.

Commenting on these results, Dr Morris said: 'There may well be a public perception that male fertility is independent of age. Stories of celebrity men fathering children into their 60s may give a skewed perspective on the potential risks of delaying fatherhood. Indeed, in natural conception and pregnancy it is only recently that evidence of risks associated with later fatherhood has become available. These more recent studies contrast with decades of evidence of the impact that maternal age has on fertility outcomes.(2)

'In the context of this emerging evidence for the deleterious effect of increasing paternal age, our data certainly support the importance of educating men about their fertility and the risks of delaying fatherhood.'

This study was observational and not designed to investigate any biological explanation for its findings. However, Dr Morris said that the data 'suggest that semen quality decreases with increasing age and that this decline mirrors the decline in IVF outcome which we found'. It's for this reason, he explained, that some centres limit the age of their sperm donors (usually up to the age of around 40). While some clinics and health authorities set an upper age limit on female IVF patients, no such limits are known to exist for males.

###

Abstract O-304, Wednesday 26 June 2019

Paternal age over 50 years reduces the success of IVF/ICSI - ET

Background notes

1. According to an 'opinion' from the American College of Obstetricians and Gynecologists and the American Society for Reproductive Medicine the decline in female fertility begins at around 32 years and decreases more rapidly after the age of 37. In assisted reproduction all national registries show a decline in success rates beginning at around the age of 35. For example, the latest figures from the UK show a live birth rate of 30% for 35s and under using their own fresh (non-frozen) eggs declining to less than 5% for those over 43. This trend is not evident in women using donor eggs.

2. A recent large population study in the USA found a negative correlation between age and routine semen parameters (volume, sperm count, total motile spermatozoa, etc). (See Veron GL, Tissera G, Bello R, et al. Impact of age, clinical conditions, and lifestyle on routine semen parameters and sperm kinematics. Fertil Steril 2018; 110: 68-75.)

The WHO reference values for semen quality are:

- sperm concentration 15 million sperms per ml or more

- total sperm count 39 million sperms per ejaculate or more

- total motility defined as 40% or more motile or 32% or more with progressive motility.

See also Khandwala YS, Baker VL, Shaw GM, et al. Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study. BMJ 2018; 363: k4372.

* When obtaining outside comment, journalists are requested to ensure that their contacts are aware of the embargo on this release.

For further information on the details of this press release, contact:

Christine Bauquis at ESHRE
Mobile: +32 (0)499 25 80 46
Email: christine@eshre.eu

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.